Sherko Abdullah Molah Karim1, Hawar Hasan Ali Ghalib2, Sangar Abdullah Mohammed3, Fattah Hama Rahim Fattah4. 1. Department of Surgery, Ranya General Hospital in Ranya Province, Sulaimanyah Governorate, Iraq. Electronic address: sherkoabdullah@yahoo.com. 2. Sulaimani University, Iraq. Electronic address: drhawar@yahoo.co.uk. 3. Teaching Hospital of Sulaimanyah, Iraq. Electronic address: sangarnawroly@yahoo.com. 4. Sulaimani University, Iraq. Electronic address: drhawramane@gmail.com.
Abstract
BACKGROUND: Studies on breast cancer among Iraqi Kurdish are limited. The incidence of breast cancer is lower, more common in younger age and a significant proportion of cases occur in premenopausal women. The aims of this study are to estimate the age-standardized incidence rate, age-specific rates and their comparison with some countries of Middle-East and West, and clarify the association of family history and premenopausal status with breast cancer. MATERIALS AND METHODS: This retrospective case control study was conducted in Sulaimanyah governorate (North of Iraq). Data were collected regarding demographical profile of 536 patients who were registered in Hewa Hematology and Oncology Hospital during 2011-2013, and 496 age-matched controls. RESULTS: There were 536 cases of breast cancer, 526 of them were female. The age range was 20-82 years. The mean age at diagnosis was 49.42±11.66 years compared to control 46.7±10.2 (p˂0.001, 95% CI: 1.7-3.7). The age-standardized rate was 17.9/100,000 Kurdish women population/year. Five year age-specific rates show the peak incidence for the age group 45-49 years (79.3/100,000). A significant percentage of patients were premenopausal at the time of diagnosis, which is account 55.52% of cases compared to control 59.67% (p=0.53). About 13.49% of cases have family history of breast cancer compared to control 3.2% (p=0.02). CONCLUSION: Among Kurdish people in Iraq, the incidence of breast cancer is less than Middle-East and Western countries with higher incidence in younger age group than western society, but similar to Middle-East countries. More than half of Kurdish women with breast cancer are premenopausal.
BACKGROUND: Studies on breast cancer among Iraqi Kurdish are limited. The incidence of breast cancer is lower, more common in younger age and a significant proportion of cases occur in premenopausal women. The aims of this study are to estimate the age-standardized incidence rate, age-specific rates and their comparison with some countries of Middle-East and West, and clarify the association of family history and premenopausal status with breast cancer. MATERIALS AND METHODS: This retrospective case control study was conducted in Sulaimanyah governorate (North of Iraq). Data were collected regarding demographical profile of 536 patients who were registered in Hewa Hematology and Oncology Hospital during 2011-2013, and 496 age-matched controls. RESULTS: There were 536 cases of breast cancer, 526 of them were female. The age range was 20-82 years. The mean age at diagnosis was 49.42±11.66 years compared to control 46.7±10.2 (p˂0.001, 95% CI: 1.7-3.7). The age-standardized rate was 17.9/100,000 Kurdish women population/year. Five year age-specific rates show the peak incidence for the age group 45-49 years (79.3/100,000). A significant percentage of patients were premenopausal at the time of diagnosis, which is account 55.52% of cases compared to control 59.67% (p=0.53). About 13.49% of cases have family history of breast cancer compared to control 3.2% (p=0.02). CONCLUSION: Among Kurdish people in Iraq, the incidence of breast cancer is less than Middle-East and Western countries with higher incidence in younger age group than western society, but similar to Middle-East countries. More than half of Kurdish women with breast cancer are premenopausal.
Authors: Karwan M-Amen; Omiad S Abdullah; Ahmed M S Amin; Zeki Ali Mohamed; Bestoon Hasan; Mudhir Shekha; Hastyar H Najmuldeen; Fryad Majeed Rahman; Zjwan Housein; Ahmed M Salih; Amin Salih Mohammed; Luqman Rahman Sulaiman; Basak Tahir Barzingi; Dler Mahmood; Hemin Esmael Othman; Dara K Mohammad; Fahmi M Salih; Suad As Khudhur Ali; Trefa S Mohamad; Kazhan Mahmood; Galawezh O Othman; Mukhlis H Aali; Govand Qader; Bashdar M Hussen; Farhang A Awla; Shahab Wahhab Kareem; Fikry A Qadir; Dilan M Taher; Abbas Salihi Journal: Asian Pac J Cancer Prev Date: 2022-02-01
Authors: Soha R Dargham; Sumeja Zahirovic; Mohammed Hammoudeh; Samar Al Emadi; Basel K Masri; Hussein Halabi; Humeira Badsha; Imad Uthman; Ziyad R Mahfoud; Hadil Ashour; Wissam Gad El Haq; Karim Bayoumy; Marianthi Kapiri; Richa Saxena; Robert M Plenge; Layla Kazkaz; Thurayya Arayssi Journal: PLoS One Date: 2018-12-19 Impact factor: 3.240
Authors: Hawar Hasan Ali Ghalib; Dawan Hiwa Ali; Sherko Abdullah Molah Karim; Mohammed Ibrahim Mohialdeen Gubari; Saman Ahmed Mohammed; Diyar Hassan Marif; Hawsar Mohammed Othman Journal: J Family Med Prim Care Date: 2019-12-10
Authors: Arnol T Z Tiofack; Gustave Simo; Elvis Ofon; Esther Dina-Bell; Chancelin M Kamla; Sidonie N Ananga; Tchamfong Roger; Theophile N Nana; Charlotte T Ngeufack; Adamou Fewou; Samuel Takongmo; Smiths Lueong Journal: Asian Pac J Cancer Prev Date: 2020-08-01